CA-37461/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
1984	1
1985	2
1986	1
1987	3
1992	1
1993	1
2024	0

1

Risk of nosocomial infection with human T-cell lymphotropic virus III (HTLV-III).

Hirsch MS, Wormser GP, Schooley RT, Ho DD, Felsenstein D, Hopkins CC, Joline C, Duncanson F, Sarngadharan MG, Saxinger C, et al. Hirsch MS, et al. N Engl J Med. 1985 Jan 3;312(1):1-4. doi: 10.1056/NEJM198501033120101. N Engl J Med. 1985. PMID: 2981106

2

HTLV-III in the semen and blood of a healthy homosexual man.

Ho DD, Schooley RT, Rota TR, Kaplan JC, Flynn T, Salahuddin SZ, Gonda MA, Hirsch MS. Ho DD, et al. Science. 1984 Oct 26;226(4673):451-3. doi: 10.1126/science.6208608. Science. 1984. PMID: 6208608

3

Status of immune-based therapies in HIV infection and AIDS.

Fahey JL, Schooley R. Fahey JL, et al. Clin Exp Immunol. 1992 Apr;88(1):1-5. doi: 10.1111/j.1365-2249.1992.tb03029.x. Clin Exp Immunol. 1992. PMID: 1563093 Free PMC article. Review.

4

Infection of the retina by human immunodeficiency virus type I.

Pomerantz RJ, Kuritzkes DR, de la Monte SM, Rota TR, Baker AS, Albert D, Bor DH, Feldman EL, Schooley RT, Hirsch MS. Pomerantz RJ, et al. N Engl J Med. 1987 Dec 24;317(26):1643-7. doi: 10.1056/NEJM198712243172607. N Engl J Med. 1987. PMID: 3479685 No abstract available.

5

Effects of human immunodeficiency virus on the cellular immune response to Epstein-Barr virus in homosexual men: characterization of the cytotoxic response and lymphokine production.

Blumberg RS, Paradis T, Byington R, Henle W, Hirsch MS, Schooley RT. Blumberg RS, et al. J Infect Dis. 1987 May;155(5):877-90. doi: 10.1093/infdis/155.5.877. J Infect Dis. 1987. PMID: 3031170

6

Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome.

Ho DD, Rota TR, Schooley RT, Kaplan JC, Allan JD, Groopman JE, Resnick L, Felsenstein D, Andrews CA, Hirsch MS. Ho DD, et al. N Engl J Med. 1985 Dec 12;313(24):1493-7. doi: 10.1056/NEJM198512123132401. N Engl J Med. 1985. PMID: 2999591

7

[Chemotherapy and immunoprophylaxis of HIV infection].

Vogt M, Schooley RT, Hirsch MS. Vogt M, et al. Schweiz Rundsch Med Prax. 1986 Nov 25;75(48):1471-5. Schweiz Rundsch Med Prax. 1986. PMID: 2432642 Clinical Trial. German. No abstract available.

8

Cytotoxic T lymphocyte lines specific for human immunodeficiency virus type 1 Gag and reverse transcriptase derived from a vertically infected child.

McFarland EJ, Curiel TJ, Schoen DJ, Rosandich ME, Schooley RT, Kuritzkes DR. McFarland EJ, et al. J Infect Dis. 1993 Mar;167(3):719-23. doi: 10.1093/infdis/167.3.719. J Infect Dis. 1993. PMID: 7680062

9

Antibody-dependent cell-mediated cytotoxicity against cells infected with the human immunodeficiency virus.

Blumberg RS, Paradis T, Hartshorn KL, Vogt M, Ho DD, Hirsch MS, Leban J, Sato VL, Schooley RT. Blumberg RS, et al. J Infect Dis. 1987 Dec;156(6):878-84. doi: 10.1093/infdis/156.6.878. J Infect Dis. 1987. PMID: 3479500

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

9 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year